TP53 and colorectal carcinoma: We then tested the effect of FUT8 expression on survival outcome using two independent cohorts based on immunohistochemistry (IHC) and microarray analysis for patients with stage II and III CRC, and its prognostic values were further addressed in conjunction with the p53 alteration status.